A detailed history of Susquehanna International Group, LLP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 12,454 shares of TARS stock, worth $658,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,454
Previous 246,500 94.95%
Holding current value
$658,941
Previous $6.7 Million 93.89%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.54 - $34.6 $268,259 - $430,908
12,454 New
12,454 $409,000
Q1 2024

May 07, 2024

SELL
$19.61 - $39.22 $596,712 - $1.19 Million
-30,429 Reduced 33.28%
60,994 $2.22 Million
Q4 2023

Feb 14, 2024

BUY
$12.98 - $20.73 $1.19 Million - $1.9 Million
91,423 New
91,423 $1.85 Million
Q2 2023

Aug 11, 2023

BUY
$11.57 - $19.63 $375,272 - $636,699
32,435 New
32,435 $586,000
Q3 2022

Nov 14, 2022

BUY
$14.08 - $18.5 $200,738 - $263,754
14,257 New
14,257 $244,000

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.41B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.